A framework for in vitro systems toxicology assessment of e-liquids

Abstract Various electronic nicotine delivery systems (ENDS), of which electronic cigarettes (e-cigs) are the most recognized prototype, have been quickly gaining ground on conventional cigarettes because they are perceived as less harmful. Research assessing the potential effects of ENDS exposure in humans is currently limited and inconclusive. New products are emerging with numerous variations in designs and performance parameters within and across brands. Acknowledging these challenges, we present here a proposed framework for an in vitro systems toxicology assessment of e-liquids and their aerosols, intended to complement the battery of assays for standard toxicity assessments. The proposed framework utilizes high-throughput toxicity assessments of e-liquids and their aerosols, in which the device-to-device variability is minimized, and a systems-level investigation of the cellular mechanisms of toxicity is an integral part. An analytical chemistry investigation is also included as a part of the framework to provide accurate and reliable chemistry data solidifying the toxicological assessment. In its simplest form, the framework comprises of three main layers: (1) high-throughput toxicity screening of e-liquids using primary human cell culture systems; (2) toxicity-related mechanistic assessment of selected e-liquids, and (3) toxicity-related mechanistic assessment of their aerosols using organotypic air–liquid interface airway culture systems. A systems toxicology assessment approach is leveraged to enable in-depth analyses of the toxicity-related cellular mechanisms of e-liquids and their aerosols. We present example use cases to demonstrate the suitability of the framework for a robust in vitro assessment of e-liquids and their aerosols.

[1]  M. Peitsch,et al.  High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC) , 2016, Journal of visualized experiments : JoVE.

[2]  Donna C. Smith,et al.  Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. , 2016, Regulatory toxicology and pharmacology : RTP.

[3]  R. Polosa,et al.  Counseling patients with asthma and allergy about electronic cigarettes: an evidence-based approach. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  Rémi H. J. Dulize,et al.  In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette. , 2016, Chemical research in toxicology.

[5]  N. Vij,et al.  Airway exposure of e‐cigarette‐vapors impairs autophagy and induces aggresome‐formation , 2015, Antioxidants & redox signaling.

[6]  David M. Reif,et al.  Toxicity Testing in the 21st Century Beyond Environmental Chemicals , 2018, ALTEX.

[7]  M. Peitsch,et al.  Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[8]  M. Peitsch,et al.  Systems Biology Reveals Cigarette Smoke-Induced Concentration-Dependent Direct and Indirect Mechanisms That Promote Monocyte-Endothelial Cell Adhesion. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  K. Farsalinos,et al.  Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes) , 2015, Risk management and healthcare policy.

[10]  Oksana Sirenko,et al.  High-Content Assays for Characterizing the Viability and Morphology of 3D Cancer Spheroid Cultures , 2015, Assay and drug development technologies.

[11]  K. Farsalinos,et al.  E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. , 2015, Addiction.

[12]  A. Malhotra,et al.  The Need for More E-Cigarette Data: A Call to Action. , 2015, American journal of respiratory and critical care medicine.

[13]  C. Meredith,et al.  An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids. , 2015, Regulatory toxicology and pharmacology : RTP.

[14]  Manuel C. Peitsch,et al.  Impact Assessment of Cigarette Smoke Exposure on Organotypic Bronchial Epithelial Tissue Cultures: A Comparison of Mono-Culture and Coculture Model Containing Fibroblasts , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  M. Goniewicz,et al.  Variations in Label Information and Nicotine Levels in Electronic Cigarette Refill Liquids in South Korea: Regulation Challenges , 2015, International journal of environmental research and public health.

[16]  Jennifer Park,et al.  Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems , 2015, Database J. Biol. Databases Curation.

[17]  J. Pankow,et al.  Flavour chemicals in electronic cigarette fluids , 2015, Tobacco Control.

[18]  D. Branscheid,et al.  Evaluation of E-Cigarette Liquid Vapor and Mainstream Cigarette Smoke after Direct Exposure of Primary Human Bronchial Epithelial Cells , 2015, International journal of environmental research and public health.

[19]  C. Vardavas,et al.  Electronic Cigarettes: The Issues behind the Moral Quandary , 2015 .

[20]  R. Draisci,et al.  The chemical components of electronic cigarette cartridges and refill fluids: review of analytical methods. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[21]  R. Crystal,et al.  Cilia dysfunction in lung disease. , 2015, Annual review of physiology.

[22]  P. Talbot,et al.  Puffing Topography and Nicotine Intake of Electronic Cigarette Users , 2015, PloS one.

[23]  Hongwei Yao,et al.  Vapors Produced by Electronic Cigarettes and E-Juices with Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung Epithelial Cells and in Mouse Lung , 2015, PloS one.

[24]  N. Saliba,et al.  Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  P. Talbot,et al.  Nicotine concentrations in electronic cigarette refill and do-it-yourself fluids. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[26]  Jennifer A. Hobin,et al.  Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology , 2015, Clinical Cancer Research.

[27]  Jennifer A. Hobin,et al.  Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology , 2015, Clinical Cancer Research.

[28]  P. Avino,et al.  Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers. , 2015, Environmental pollution.

[29]  Catherine Mahony,et al.  The SEURAT-1 approach towards animal free human safety assessment. , 2015, ALTEX.

[30]  C. Bullen,et al.  Electronic cigarettes for smoking cessation and reduction. , 2014, The Cochrane database of systematic reviews.

[31]  C. Shamu,et al.  An introduction to high content screening : imaging technology, assay development, and data analysis in biology and drug discovery , 2014 .

[32]  B. Cooper,et al.  Comparative In Vitro Toxicity Profile of Electronic and Tobacco Cigarettes, Smokeless Tobacco and Nicotine Replacement Therapy Products: E-Liquids, Extracts and Collected Aerosols , 2014, International journal of environmental research and public health.

[33]  Marcel Geertz,et al.  The Response of Human Nasal and Bronchial Organotypic Tissue Cultures to Repeated Whole Cigarette Smoke Exposure , 2014, International journal of toxicology.

[34]  Andrzej Sobczak,et al.  Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[35]  H. Chu,et al.  Electronic Cigarette Liquid Increases Inflammation and Virus Infection in Primary Human Airway Epithelial Cells , 2014, PloS one.

[36]  Song Huang,et al.  The Use of in vitro 3D Cell Models of Human Airway Epithelia (MucilAirTM) in Inhalation Toxicity , 2014 .

[37]  Manuel C. Peitsch,et al.  In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures , 2014, Toxicology mechanisms and methods.

[38]  Yang Xiang,et al.  Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models , 2014, BMC Bioinformatics.

[39]  David J. Foran,et al.  High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately , 2014, Journal of visualized experiments : JoVE.

[40]  Anthony Gamst,et al.  Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation , 2014, Tobacco Control.

[41]  T. Padhya,et al.  Electronic Nicotine Delivery Systems (“E-cigarettes”) , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[42]  Michael S Orr,et al.  Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future , 2014, Tobacco Control.

[43]  Christopher J Brown,et al.  Electronic cigarettes: product characterisation and design considerations , 2014, Tobacco Control.

[44]  Priscilla Callahan-Lyon,et al.  Electronic cigarettes: human health effects , 2014, Tobacco Control.

[45]  K. Fagerström,et al.  Tobacco harm reduction: the need for new products that can compete with cigarettes. , 2014, Addictive behaviors.

[46]  M. Oldham,et al.  Toxicological evaluation of aerosols of a tobacco extract formulation and nicotine formulation in acute and short-term inhalation studies , 2014, Inhalation toxicology.

[47]  Riccardo Polosa,et al.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review , 2014, Therapeutic advances in drug safety.

[48]  Julia Hoeng,et al.  Case study: the role of mechanistic network models in systems toxicology. , 2014, Drug discovery today.

[49]  R. Bhisey.  WHO Study Group on Tobacco Product Regulation. Report on the scientific basic of tobacco product regulation: fourth report of a WHO study group. , 2012, World Health Organization technical report series.

[50]  Rémi H. J. Dulize,et al.  Systems biology approach for evaluating the biological impact of environmental toxicants in vitro. , 2014, Chemical research in toxicology.

[51]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[52]  Julia Hoeng,et al.  Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. , 2013, Toxicology and applied pharmacology.

[53]  J. Adamson,et al.  A review of in vitro cigarette smoke exposure systems. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[54]  K. Farsalinos,et al.  Comparison of the Cytotoxic Potential of Cigarette Smoke and Electronic Cigarette Vapour Extract on Cultured Myocardial Cells , 2013, International journal of environmental research and public health.

[55]  T. Leisner,et al.  Modelling and measurement of particle deposition for cell exposure at the air–liquid interface , 2013 .

[56]  K. Farsalinos,et al.  Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract , 2013, Inhalation toxicology.

[57]  M. Peitsch,et al.  Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[58]  C. de Jager,et al.  What should it take to describe a substance or product as 'sperm-safe'. , 2013, Human reproduction update.

[59]  W. Han,et al.  High-throughput library screening identifies two novel NQO1 inducers in human lung cells. , 2012, American journal of respiratory cell and molecular biology.

[60]  J. Seagrave,et al.  Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells , 2012, Respiratory Research.

[61]  W. Goldsmith,et al.  Cardiovascular , Pulmonary , and Renal Pathology Respiratory and Olfactory Cytotoxicity of Inhaled 2 , 3-Pentanedione in Sprague-Dawley Rats , 2012 .

[62]  G. Oberdörster,et al.  Nanotoxicology: in Vitro–in Vivo Dosimetry , 2012, Environmental health perspectives.

[63]  Or.  Guidance for Industry S 2 ( R 1 ) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use , 2012 .

[64]  Petr Pohunek,et al.  ciliaFA: a research tool for automated, high-throughput measurement of ciliary beat frequency using freely available software , 2012, Cilia.

[65]  Manuel C. Peitsch,et al.  Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks , 2012, BMC Systems Biology.

[66]  Gerhard Kasper,et al.  In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung - A dialog between aerosol science and biology , 2011 .

[67]  D. Proud,et al.  Epithelial cells and airway diseases , 2011, Immunological reviews.

[68]  Cyrille Krul,et al.  Toxicology in the 21st century--working our way towards a visionary reality. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[69]  B. Stockwell,et al.  High-Throughput and High-Content Screening for Huntington’s Disease Therapeutics , 2011 .

[70]  Xiao Xu,et al.  The xCELLigence system for real-time and label-free monitoring of cell viability. , 2011, Methods in molecular biology.

[71]  M. Balls.  ATLA (Alternatives to Laboratory Animals): Past, Present and Future a , 2010, Alternatives to laboratory animals : ATLA.

[72]  Rafael A Irizarry,et al.  Frozen robust multiarray analysis (fRMA). , 2010, Biostatistics.

[73]  R. Crystal,et al.  Smoking Is Associated with Shortened Airway Cilia , 2009, PloS one.

[74]  P. Shields,et al.  Evaluation of In vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[75]  B. S. Manjunath,et al.  Soluble Intercellular Adhesion Molecule-1 and E-selectin in Patients with Asthma Exacerbation , 2009, Lung.

[76]  I. Adcock,et al.  Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD , 2009, Thorax.

[77]  Laurent Schwartz,et al.  Is inflammation a consequence of extracellular hyperosmolarity? , 2009, Journal of Inflammation.

[78]  M. Stämpfli,et al.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer , 2009, Nature Reviews Immunology.

[79]  Elaine A. Cohen Hubal,et al.  Exposure as Part of a Systems Approach for Assessing Risk , 2009, Environmental health perspectives.

[80]  E. Holbrook,et al.  Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5 expression in chronic rhinosinusitis. , 2008, The Journal of allergy and clinical immunology.

[81]  P. Barnes,et al.  CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. , 2008, Chest.

[82]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[83]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Uc San Francisco,et al.  Guiding Principles for the Development of Tobacco Product Research and Testing Capacity and Proposed Protocols for the Initiation of Tobacco Product Testing , 2005 .

[85]  James Inglese,et al.  Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content Imaging -- Assay Guidance Manual , 2014 .

[86]  Z. Darżynkiewicz,et al.  Induction of H2AX Phosphorylation in Pulmonary Cells by Tobacco Smoke: A New Assay for Carcinogens , 2004, Cell cycle.

[87]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[88]  Josue P. Keely,et al.  Shape of the relapse curve and long-term abstinence among untreated smokers. , 2004, Addiction.

[89]  J. Reynolds,et al.  Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring. , 2002, Toxicology and applied pharmacology.

[90]  Katie Chan,et al.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[91]  C. Roth,et al.  Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface , 2002 .

[92]  D. Veltel,et al.  Evaluation of the potential effects of ingredients added to cigarettes. Part 3: in vitro genotoxicity and cytotoxicity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[93]  A. Penn,et al.  Combustion products of 1,3-butadiene are cytotoxic and genotoxic to human bronchial epithelial cells. , 2001, Environmental health perspectives.

[94]  R. Wallace,et al.  Implementation of a Science-Based Policy of Harm Reduction , 2001 .

[95]  R. Wallace,et al.  COMMITTEE TO ASSESS THE SCIENCE BASE FOR TOBACCO HARM REDUCTION , 2001 .

[96]  R. Davies,et al.  Effect of Cigarette Smoke on the Permeability and IL-1 β and sICAM-1 Release from Cultured Human Bronchial Epithelial Cells of Never-Smokers, Smokers, and Patients with Chronic Obstructive Pulmonary Disease , 2000 .

[97]  R. Davies,et al.  Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory cell and molecular biology.

[98]  I. Katkov,et al.  Mouse spermatozoa in high concentrations of glycerol: chemical toxicity vs osmotic shock at normal and reduced oxygen concentrations. , 1998, Cryobiology.

[99]  S. Gebel,et al.  Heme oxygenase expression in Swiss 3T3 cells following exposure to aqueous cigarette smoke fractions. , 1994, Carcinogenesis.

[100]  A. Nakai,et al.  Exercise-Induced Urinary Excretion of Leukotriene E4 in Children with Atopic Asthma , 1991, Pediatric Research.